Inventor · disambiguated record
Stevan Graham Shaw
Also filed as: SHAW STEVAN · SHAW STEVAN GRAHAM
8 granted patents·4 pending applications·70 citations·filing 2008–2025
84Inventor score
Files withUCB Biopharma SRL4UCB BIOPHARMA SPRL3UCB PHARMA SA2LAWSON ALASTAIR DAVID GRIFFITHS1MARSHALL DIANE1
Top patents by PatentIndex Score
12 records- 0194US8614295B2Antibody molecules having specificity for human OX40LAWSON ALASTAIR DAVID GRIFFITHS·Filed 2010·Granted Dec 24, 2013·41 cites·29 claims
- 0291US9428570B2Antibody molecules having specificity for human OX40UCB PHARMA SA·Filed 2013·Granted Aug 30, 2016·18 cites·22 claims
- 0388US10233243B2Anti-FcRn antibodiesUCB BIOPHARMA SPRL·Filed 2013·Granted Mar 19, 2019·10 cites·17 claims
- 0483US2025346672A1Anti-fcrn antibodiesUCB Biopharma SRL·Filed 2025·Application pending·0 cites
- 0580US12338285B2Anti-FcRn antibodiesUCB Biopharma SRL·Filed 2022·Granted Jun 24, 2025·0 cites·52 claims
- 0680US11384148B2Anti-FcRn antibodiesUCB BIOPHARMA SPRL·Filed 2019·Granted Jul 12, 2022·1 cites·16 claims
- 0764US2023279093A1Methods of Treatment Using Anti-IL-17A/F AntibodiesUCB Biopharma SRL·Filed 2022·Application pending·0 cites
- 0864US2023287100A1Methods of Treatment Using Anti-IL-17A/F AntibodiesUCB Biopharma SRL·Filed 2022·Application pending·0 cites
- 0957US10017575B2Antibody molecules having specificity for human OX40UCB PHARMA SA·Filed 2016·Granted Jul 10, 2018·0 cites·32 claims
- 1050US11492396B2Methods of treatment using anti-IL-17A/F antibodiesUCB BIOPHARMA SPRL·Filed 2016·Granted Nov 8, 2022·0 cites·12 claims
- 1150US9321837B2Method for the treatment of glomerulonephritis by administering an IL-6 antibodyMARSHALL DIANE·Filed 2008·Granted Apr 26, 2016·0 cites·9 claims
- 1238US2020277366A1MULTI-SPECIFIC ANTIBODY MOLECULES HAVING SPECIFICITY FOR TNF-ALPHA, IL-17A and IL-17FUCB BIOPHRMA SPRL·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stevan Graham Shaw files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →